OverviewChartNewsTraderScreen

DZ Bank Discount Zert BNTX 28.06..../  DE000DJ6M3C9  /

Frankfurt Zert./DZB
18/06/2024  17:34:54 Chg.-0.020 Bid17:41:03 Ask17:41:03 Underlying Strike price Expiration date Option type
69.900EUR -0.03% 69.890
Bid Size: 250		 69.920
Ask Size: 250		 BioNTech SE - USD 28/06/2024 Call
GlobeNewswire 01/06 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 29/05 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 28/05 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 21/05 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 21/05 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 17/05 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 17/05 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire 09/05 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
TeleTrader 06/05 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 06/05 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
TeleTrader 06/05 Europe mixed premarket with data on the limelight
GlobeNewswire 02/05 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 22/04 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 10/04 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire 07/04 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 04/04 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 28/03 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 27/03 Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
TeleTrader 20/03 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 20/03 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 20/03 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
TeleTrader 20/03 Europe mixed premarket amid data
GlobeNewswire 14/03 Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire 12/03 The Gross Law Firm Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline – ...
GlobeNewswire 11/03 BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Co...